279 related articles for article (PubMed ID: 33743207)
1. Spectrum of splicing variants in disease genes and the ability of RNA analysis to reduce uncertainty in clinical interpretation.
Truty R; Ouyang K; Rojahn S; Garcia S; Colavin A; Hamlington B; Freivogel M; Nussbaum RL; Nykamp K; Aradhya S
Am J Hum Genet; 2021 Apr; 108(4):696-708. PubMed ID: 33743207
[TBL] [Abstract][Full Text] [Related]
2. Rates and Classification of Variants of Uncertain Significance in Hereditary Disease Genetic Testing.
Chen E; Facio FM; Aradhya KW; Rojahn S; Hatchell KE; Aguilar S; Ouyang K; Saitta S; Hanson-Kwan AK; Capurro NN; Takamine E; Jamuar SS; McKnight D; Johnson B; Aradhya S
JAMA Netw Open; 2023 Oct; 6(10):e2339571. PubMed ID: 37878314
[TBL] [Abstract][Full Text] [Related]
3. SEPT-GD: A decision tree to prioritise potential RNA splice variants in cardiomyopathy genes for functional splicing assays in diagnostics.
Alimohamed MZ; Boven LG; van Dijk KK; Vos YJ; Hoedemaekers YM; van der Zwaag PA; Sijmons RH; Jongbloed JDH; Sikkema-Raddatz B; Westers H
Gene; 2023 Jan; 851():146984. PubMed ID: 36270459
[TBL] [Abstract][Full Text] [Related]
4. Key Value of RNA Analysis of MYBPC3 Splice-Site Variants in Hypertrophic Cardiomyopathy.
Singer ES; Ingles J; Semsarian C; Bagnall RD
Circ Genom Precis Med; 2019 Jan; 12(1):e002368. PubMed ID: 30645170
[TBL] [Abstract][Full Text] [Related]
5. Comparison of in silico strategies to prioritize rare genomic variants impacting RNA splicing for the diagnosis of genomic disorders.
Rowlands C; Thomas HB; Lord J; Wai HA; Arno G; Beaman G; Sergouniotis P; Gomes-Silva B; Campbell C; Gossan N; Hardcastle C; Webb K; O'Callaghan C; Hirst RA; Ramsden S; Jones E; Clayton-Smith J; Webster AR; ; Douglas AGL; O'Keefe RT; Newman WG; Baralle D; Black GCM; Ellingford JM
Sci Rep; 2021 Oct; 11(1):20607. PubMed ID: 34663891
[TBL] [Abstract][Full Text] [Related]
6. Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18.
Fraile-Bethencourt E; Díez-Gómez B; Velásquez-Zapata V; Acedo A; Sanz DJ; Velasco EA
PLoS Genet; 2017 Mar; 13(3):e1006691. PubMed ID: 28339459
[TBL] [Abstract][Full Text] [Related]
7. Systematic Computational Identification of Variants That Activate Exonic and Intronic Cryptic Splice Sites.
Lee M; Roos P; Sharma N; Atalar M; Evans TA; Pellicore MJ; Davis E; Lam AN; Stanley SE; Khalil SE; Solomon GM; Walker D; Raraigh KS; Vecchio-Pagan B; Armanios M; Cutting GR
Am J Hum Genet; 2017 May; 100(5):751-765. PubMed ID: 28475858
[TBL] [Abstract][Full Text] [Related]
8. Clinical Utility of Functional RNA Analysis for the Reclassification of Splicing Gene Variants in Hereditary Cancer.
Agiannitopoulos K; Pepe G; Papadopoulou E; Tsaousis GN; Kampouri S; Maravelaki S; Fassas A; Christodoulou C; Iosifidou R; Karageorgopoulou S; Markopoulos C; Natsiopoulos I; Papazisis K; Vasilaki-Antonatou M; Venizelos V; Ozmen V; Tansan S; Kaban K; Eniu DT; Chiorean A; Nasioulas G
Cancer Genomics Proteomics; 2021; 18(3):285-294. PubMed ID: 33893081
[TBL] [Abstract][Full Text] [Related]
9. RNA splicing analysis contributes to reclassifying variants of uncertain significance and improves the diagnosis of monogenic disorders.
He WB; Xiao WJ; Dai CL; Wang YR; Li XR; Gong F; Meng LL; Tan C; Zeng SC; Lu GX; Lin G; Tan YQ; Hu H; Du J
J Med Genet; 2022 Oct; 59(10):1010-1016. PubMed ID: 35121647
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Diagnostic Outcomes of RNA Genetic Testing for Hereditary Cancer.
Karam R; Conner B; LaDuca H; McGoldrick K; Krempely K; Richardson ME; Zimmermann H; Gutierrez S; Reineke P; Hoang L; Allen K; Yussuf A; Farber-Katz S; Rana HQ; Culver S; Lee J; Nashed S; Toppmeyer D; Collins D; Haynes G; Pesaran T; Dolinsky JS; Tippin Davis B; Elliott A; Chao E
JAMA Netw Open; 2019 Oct; 2(10):e1913900. PubMed ID: 31642931
[TBL] [Abstract][Full Text] [Related]
11. Identification of Spliceogenic Variants beyond Canonical GT-AG Splice Sites in Hereditary Cancer Genes.
Dragoš VŠ; Strojnik K; Klančar G; Škerl P; Stegel V; Blatnik A; Banjac M; Krajc M; Novaković S
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806449
[TBL] [Abstract][Full Text] [Related]
12. Identification of pathogenic gene mutations in
Ito K; Patel PN; Gorham JM; McDonough B; DePalma SR; Adler EE; Lam L; MacRae CA; Mohiuddin SM; Fatkin D; Seidman CE; Seidman JG
Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7689-7694. PubMed ID: 28679633
[TBL] [Abstract][Full Text] [Related]
13. A Systematic Method for Detecting Abnormal mRNA Splicing and Assessing Its Clinical Impact in Individuals Undergoing Genetic Testing for Hereditary Cancer Syndromes.
Kamps-Hughes N; Carlton VEH; Fresard L; Osazuwa S; Starks E; Vincent JJ; Albritton S; Nussbaum RL; Nykamp K
J Mol Diagn; 2023 Mar; 25(3):156-167. PubMed ID: 36563937
[TBL] [Abstract][Full Text] [Related]
14. Curated multiple sequence alignment for the Adenomatous Polyposis Coli (APC) gene and accuracy of in silico pathogenicity predictions.
Karabachev AD; Martini DJ; Hermel DJ; Solcz D; Richardson ME; Pesaran T; Sarkar IN; Greenblatt MS
PLoS One; 2020; 15(8):e0233673. PubMed ID: 32750050
[TBL] [Abstract][Full Text] [Related]
15. Somatic mRNA Analysis of BRCA1 Splice Variants Provides a Direct Theranostic Impact on PARP Inhibitors.
Chevalier LM; Billaud A; Fronteau S; Dauvé J; Patsouris A; Verriele V; Morel A
Mol Diagn Ther; 2020 Apr; 24(2):233-243. PubMed ID: 32124385
[TBL] [Abstract][Full Text] [Related]
16. Blood RNA analysis can increase clinical diagnostic rate and resolve variants of uncertain significance.
Wai HA; Lord J; Lyon M; Gunning A; Kelly H; Cibin P; Seaby EG; Spiers-Fitzgerald K; Lye J; Ellard S; Thomas NS; Bunyan DJ; Douglas AGL; Baralle D;
Genet Med; 2020 Jun; 22(6):1005-1014. PubMed ID: 32123317
[TBL] [Abstract][Full Text] [Related]
17. Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members.
Thomassen M; Blanco A; Montagna M; Hansen TV; Pedersen IS; Gutiérrez-Enríquez S; Menéndez M; Fachal L; Santamariña M; Steffensen AY; Jønson L; Agata S; Whiley P; Tognazzo S; Tornero E; Jensen UB; Balmaña J; Kruse TA; Goldgar DE; Lázaro C; Diez O; Spurdle AB; Vega A
Breast Cancer Res Treat; 2012 Apr; 132(3):1009-23. PubMed ID: 21769658
[TBL] [Abstract][Full Text] [Related]
18. ParSE-seq: A Calibrated Multiplexed Assay to Facilitate the Clinical Classification of Putative Splice-altering Variants.
O'Neill MJ; Yang T; Laudeman J; Calandranis M; Solus J; Roden DM; Glazer AM
medRxiv; 2023 Sep; ():. PubMed ID: 37732247
[TBL] [Abstract][Full Text] [Related]
19. The Challenge of Genetic Variants of Uncertain Clinical Significance : A Narrative Review.
Burke W; Parens E; Chung WK; Berger SM; Appelbaum PS
Ann Intern Med; 2022 Jul; 175(7):994-1000. PubMed ID: 35436152
[TBL] [Abstract][Full Text] [Related]
20. Leveraging splice-affecting variant predictors and a minigene validation system to identify Mendelian disease-causing variants among exon-captured variants of uncertain significance.
Soens ZT; Branch J; Wu S; Yuan Z; Li Y; Li H; Wang K; Xu M; Rajan L; Motta FL; Simões RT; Lopez-Solache I; Ajlan R; Birch DG; Zhao P; Porto FB; Sallum J; Koenekoop RK; Sui R; Chen R
Hum Mutat; 2017 Nov; 38(11):1521-1533. PubMed ID: 28714225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
